M1 Kliniken AG (ETR:M12)
Germany · Delayed Price · Currency is EUR 18.88
+0.22 (1.18%)
Aug 4, 2026, 5:35 PM CET
M1 Kliniken AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 24.1 | 17.79 | 11.67 | 7.07 | 10.88 |
Depreciation & Amortization | 0.79 | 1.02 | 1.15 | 5.86 | 1.57 |
Other Adjustments | 11.39 | 11.16 | 6.06 | 2.42 | 3.13 |
Change in Receivables | 2.84 | 13.64 | 7.29 | -4.38 | - |
Changes in Inventories | 11.77 | 8.72 | -17.18 | 7.6 | 7.13 |
Changes in Accounts Payable | -7.95 | -20.2 | 1.02 | 4.97 | - |
Changes in Accrued Expenses | 0.19 | 0.19 | 0.02 | -0.61 | -0.49 |
Changes in Income Taxes Payable | -9.28 | -5.91 | -4.38 | -2.16 | -0.03 |
Changes in Other Operating Activities | - | - | - | - | -10.29 |
Operating Cash Flow | 37.95 | 30.55 | 7.81 | 20.77 | 15.68 |
Operating Cash Flow Growth | 24.23% | 291.14% | -62.40% | 32.41% | 64.40% |
Capital Expenditures | -0.32 | -0.23 | -0.45 | -1.16 | -1.03 |
Sale of Property, Plant & Equipment | 0.06 | 0.01 | 0.05 | 0.07 | 0.18 |
Purchases of Intangible Assets | -0.11 | -0.77 | -0.55 | -0.61 | -0.31 |
Proceeds from Sale of Intangible Assets | 0.12 | 0 | - | - | 0.01 |
Purchases of Investments | -7.34 | -6.72 | -10.27 | - | - |
Proceeds from Sale of Investments | 2.94 | 0.98 | - | - | -0 |
Cash Acquisitions | - | - | - | -0.07 | - |
Proceeds from Business Divestments | - | - | - | - | 1.08 |
Other Investing Activities | 3.44 | 1.07 | 12.89 | 0.65 | - |
Investing Cash Flow | -3.59 | -5.67 | -9.36 | -1.12 | 0.21 |
Long-Term Debt Issued | -0 | -1.88 | - | -13.4 | -4.22 |
Long-Term Debt Repaid | - | - | -24.74 | -4.59 | - |
Net Long-Term Debt Issued (Repaid) | -0 | -1.88 | -24.74 | -18 | -4.22 |
Issuance of Common Stock | - | 0.85 | 7.58 | - | 14.48 |
Repurchase of Common Stock | 0 | -14.44 | -3.63 | -2.15 | - |
Net Common Stock Issued (Repurchased) | 0 | -13.59 | 3.95 | -2.15 | 14.48 |
Common Dividends Paid | -9.31 | -9.31 | -1.98 | -1.82 | -1.66 |
Other Financing Activities | -1.2 | -1.53 | -0.89 | -0.4 | -0.51 |
Financing Cash Flow | -14.61 | -30.44 | -27.82 | -22.37 | 4.03 |
Foreign Exchange Rate Adjustments | 0.06 | -0.1 | 0.07 | -0.01 | -0.01 |
Net Cash Flow | 22.19 | -5.66 | -16.29 | -2.72 | 19.91 |
Free Cash Flow | 37.63 | 30.32 | 7.35 | 19.61 | 14.66 |
Free Cash Flow Growth | 24.11% | 312.24% | -62.49% | 33.76% | 69.77% |
FCF Margin | 10.30% | 8.91% | 2.31% | 6.84% | 4.65% |
Free Cash Flow Per Share | 1.92 | 1.54 | 0.37 | 1.00 | 0.75 |
Levered Free Cash Flow | 17.34 | -2.27 | -34.29 | 0.82 | 1.55 |
Unlevered Free Cash Flow | 21.04 | 3.21 | -8.69 | 21.93 | 6.01 |